| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.760 | 17.315 | 17.938 | 19.620 | 21.978 | 21.640 | 30.637 | 35.856 | 40.636 | 36.801 |
| Total Income - EUR | 14.762 | 17.318 | 17.939 | 19.621 | 21.979 | 22.452 | 30.638 | 35.856 | 40.637 | 36.804 |
| Total Expenses - EUR | 10.866 | 11.794 | 13.096 | 14.537 | 17.595 | 17.175 | 19.257 | 24.443 | 22.801 | 27.931 |
| Gross Profit/Loss - EUR | 3.896 | 5.524 | 4.843 | 5.084 | 4.384 | 5.277 | 11.381 | 11.413 | 17.836 | 8.873 |
| Net Profit/Loss - EUR | 3.453 | 5.177 | 4.664 | 4.888 | 4.165 | 5.069 | 11.080 | 11.055 | 17.429 | 7.769 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sanomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 56 | 2.404 | 2.696 | 2.093 | 1.509 | 2.521 | 1.388 | 3.140 | 3.055 | 1.661 |
| Current Assets | 4.046 | 3.371 | 2.681 | 3.398 | 3.372 | 3.240 | 10.388 | 8.674 | 15.406 | 24.692 |
| Inventories | 1.019 | 1.121 | 1.070 | 1.172 | 1.081 | 980 | 985 | 1.784 | 1.801 | 1.564 |
| Receivables | 4 | 534 | 540 | 626 | 631 | 621 | 816 | 1.379 | 2.496 | 0 |
| Cash | 3.023 | 1.716 | 1.071 | 1.600 | 1.660 | 1.638 | 8.587 | 5.511 | 11.108 | 23.128 |
| Shareholders Funds | 3.507 | 5.231 | 4.716 | 4.939 | 4.215 | 5.119 | 11.129 | 11.104 | 17.478 | 25.149 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 595 | 544 | 661 | 551 | 666 | 642 | 647 | 710 | 983 | 1.204 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Sanomedica Srl